SLAMF1 抗体 (AA 231-335) (Biotin)
Quick Overview for SLAMF1 抗体 (AA 231-335) (Biotin) (ABIN749470)
抗原
See all SLAMF1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 231-335
- 
                                            交叉反应
- 小鼠, 大鼠
- 
                                            预测反应
- Human,Dog,Cow,Sheep,Pig,Horse
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- KLH conjugated synthetic peptide derived from human CD150
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        WB 1:300-5000
 IHC-P 1:200-400
 IHC-F 1:100-500
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C for 12 months.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
- 
                                            别名
- CD150
- 
                                            背景
- 
                        Synonyms: SLAM, CD150, CDw150, Signaling lymphocytic activation molecule, IPO-3, SLAMF1 Background: High-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates. 
- 
                                            基因ID
- 6504
- 
                                            UniProt
- Q13291
 抗原
- 
                    
 
                                     
                                     
                                    